Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00884117 · ClinicalTrials.gov registry record

Influenza Resistance Information Study

A clinical trial, sponsored by Hoffmann-La Roche.

Completed
Registry status
4,561
Enrollment target

NCT00884117: Completed study, sponsored by Hoffmann-La Roche.

NCT00884117 is a clinical trial that has completed, run by Hoffmann-La Roche. The registered enrollment target is 4,561 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00884117 has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
4,561 participants
Enrollment target

Study Summary

This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and susceptibility. Participants clinically diagnosed with influenza will undergo a rapid diagnostic test and viral sampling at Baseline and on Days 3, 6, and 10. Participants will be clinically managed according to local guidelines and the decision to treat/not treat will be at the discretion of the Investigator.

Primary Outcome

Samples were analyzed using reverse transcriptase-polymerase chain reaction (RT-PCR). Pre-defined mutations in viral ribonucleic acid (RNA) were noted, the presence of which was defined as genotypic resistance. The number of participants with genotypic resistance at Baseline was reported. The number of participants with genotypic resistance post-Baseline was determined by a collective count of all participants who had a resistance mutation at least once on Days 3, 6, and/or 10. (Hereafter, "H" s

Interventions

  • DRUG Oseltamivir

Trial Details

FieldValue
Enrollment Target 4,561 participants
Start Date 2009-01
Est. Completion 2015-11
Hoffmann-La Roche

909 total trials

What the finished NCT00884117 record still lists

NCT00884117 is an observational study that tracks outcomes without assigning an intervention. Its 4,561 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Oseltamivir is the first listed.

NCT00884117 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00884117 about?

NCT00884117 is a clinical study titled "Influenza Resistance Information Study". This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and susceptibility. Participants clinically diagnosed with influenza will undergo a rapid diagnostic test and v...

What is the current status of trial NCT00884117?

This trial is currently completed. The enrollment target is 4,561 participants. The study started on 2009-01. Estimated completion is 2015-11.

What interventions are being tested in trial NCT00884117?

The interventions under investigation include: Oseltamivir (DRUG).

Who is sponsoring clinical trial NCT00884117?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05768217 · 4,600 participants · NA

    Community Resiliency Collective Efficacy Intervention

  • NCT06702878 · 4,514 participants · Phase 3

    Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

  • NCT06533111 · 4,500 participants · NA

    Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool

  • NCT06588452 · 4,500 participants

    Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00884117, the US trial registry maintained by the National Library of Medicine. NCT00884117 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.